PEPTIC ULCER - PowerPoint PPT Presentation

About This Presentation
Title:

PEPTIC ULCER

Description:

Title: PATHLOGY AND PATHOGENESIS OF PEPTIC ULCER Author: HP Authorized Customer Last modified by: Temp Created Date: 10/7/2003 1:10:12 AM Document presentation format – PowerPoint PPT presentation

Number of Views:753
Avg rating:3.0/5.0
Slides: 32
Provided by: HPAuthoriz1254
Category:

less

Transcript and Presenter's Notes

Title: PEPTIC ULCER


1
PEPTIC ULCER
2
  • Ulcers are defined as a breach in the mucosa of
    the alimentary tract, which extends through the
    muscularis mucosa into the submucosa or deeper.
  • ( An erosion differs from an ulcer in being
    partial thickness mucosal defect).
  • Peptic ulcers are chronic most often solitary,
    lesions that occur in any portion of
    gastrointestinal tract exposed to the aggressive
    action of acid-peptic juices.

3
DEFINITION
  • Imbalance between aggressive protective factors
  • Aggressive factors
  • Gastric acid
  • Proteolytic enzyme
  • Protective factors
  • Mucosal layer
  • Bicarbonate secretion
  • Prostaglandins

4
(No Transcript)
5
(No Transcript)
6
Gastric physiologyAcid secretion
  • The human stomach contains about 1 billion
    parietal cells
  • These are located in the walls of the
    midsection of the oxyntic glands
  • Oxyntic glands are the secretory glands of the
    gastric mucosa
  • Oxyntic glands also contin chief, mucous,
    endocrine, and somatostatin cells

7
  • There are three primary pathways that stimulate
    gastric acid secretion
  • 1) The neurocrine pathway which delivers
    transmitters such as acetylcholine
    post-ganglionic nerves on the stomach wall
  • 2) The endocrine pathway which releases hormones
    such as gastrin
  • 3) The paracrine pathway which releases histamine
  • These pathways are interdependent
  • Once pH is lt3.5, pepsinogen is converted to the
    active proteolytic enzyme pepsin

8
  • Pathogenesis of peptic ulcer
  • Peptic ulcers are produced by an imbalance
    between the gastro-duodenal mucosal defense
    mechanisms and damaging forces of gastric acid
    and pepsin, combined with superimposed injury
    from environmental or immunologic agents.

9
Imbalance (Aggressive/Defensive Factors)
  • Aggressive Factors
  • H. pylori
  • Acid Secretion
  • Pepsinogen Secretion
  • NSAIDS
  • Cigarette smoking
  • Corticosteroid use

10
  • Defensive Factors
  • Mucus Production
  • Bicarbonate Production
  • Mucosal blood flow - more important in the
    development of stress ulcer
  • High epithelial cell turnover
  • Prostaglandins (PGE2) - stimulate mucus and
    bicarbonate production, and blood flow

11
Clinical presentation
  • Remitting, relapsing lesion
  • Most often diagnosed in middle aged to older
    adults but may first become evident in young
    adult life.
  • Epigastric burning or aching pain. Pyrosis
  • Pain worse at night and 1 to 3 hours after meal.
  • Nausea, vomiting, bloating , belching and weight
    loss occur.
  • Complication Anaemia, hemorrhage, perforation,
    obstruction. Malignant formation is rare and
    related to underlying gastritis.

12
Sites of peptic ulcer
  • Duodenum First portion ( few cms from the
    pyloric ring). Anterior wall is more often
    affected.
  • Stomach Usually antrum. Lesser curvature
    (common) . Anterior and posterior wall and
    greater curvature (less common).
  • In the margins of a gastroenterostomy (stomal
    ulcer)
  • In the duodenum, stomach or jejunum of patients
    with Zollinger-Ellison syndrome.
  • Within or adjacent to a Meckels diverticulum
    that contains ectopic gastric mucosa.

13
(No Transcript)
14
(No Transcript)
15
H.Pylori
16
Role of H. Pylori infection in the pathogenesis
of peptic ulcer
  • H. pylori infection is present in almost all
    patients with duodenal ulcers and 70 cases with
    gastric ulcers.
  • Duodenal ulcers - Usually associated with
    gastritis confined to the antrum.
  • Gastric ulcers - Usually associated with
    pangastritis.
  • Mechanism
  • H. pylori secretes urease (generates ammonia),
    protease (breaks down glycoprotein in the gastric
    mucus) or phospholipases.
  • Bacterial lipopolysaccharide attracts
    inflammmatory cells to the mucosa. Neutrophils
    release myeloperoxide.
  • A bacterial platelet-activating factor promotes
    thrombotic occlusion of surface capillaries.
  • Mucosal damage allows leakage of tissue nutrients
    in the surface microenvironment , sustaining the
    bacillus.

17
H. Pylori infection in peptic ulceration
(continued)
  • Damage of the protective mucosal layer. The
    epithelial cells are exposed to the damaging
    effect of acid-peptic digestion.
  • Inflammation of the gastric mucosa.
  • Chronically inflamed mucosa more susceptible to
    acid- peptic injury and prone to peptic
    ulceration.
  • Ulcers occur at sites of chronic inflammation .
  • Eg - Antrum
  • - Junction of antral and body- fundic
    mucosa (division between the inflamed antral
    mucosa and normal acid secreting mucosa).
  • Pangastritis - When there is extensive
    gastritis, the ulcers are more proximally
    situated. In elderly patients gastric ulcers are
    more proximally situated as there is proximal
    migration of the antral-body mucosal junction.

18
Other factors causing peptic ulcer
  • Peptic ulcer caused due to high gastrin
    level and excess acid production. Gastrinoma may
    cause multiple peptic ulceration as in Zollinger
    Ellison syndrome. There is increased parietal
    cell mass.
  • Peptic ulcers caused due to impaired mucosal
    defense . The gastric acid and pepsin levels
    are normal and no H.pylori are present.
  • Chronic use of NSAIDs (aspirin) causes
    suppression of mucosal prostaglandin and direct
    irritative topical effect.
  • Repeated use of corticosteroid in high dose.
  • Cigarette smoking impair healing and favour
    recurrences.
  • Alcoholic cirrhosis.
  • Personality, psychological stress, ischemia.

19
Diagnostic Test and Procedures
  • a) Routine
  • Routine lab tests are not useful in
    establishing the diagnosis of uncomplicated PUD
  • Hct, HgB, and stool hemoccult are useful to
    detect bleeding
  • b) H.pylori test
  • Histology
  • Culture
  • Biopsy/gram stain
  • Biopsy/CLO test
  • Urea breath test
  • Serology

20
Diagnosis
  • Breath Test Carbon 14 Urea Test (see picture)
  • Blood Test
  • Endoscopy

21
Gross features
  • Gastric ulcers are usually single well delineated
    lesion.
  • Shape Round, oval or linear.
  • Size Usually less than 2cm in diameter.
  • Lesions less than 0.3 cm are likely to be
    shallow erosions.
  • Giant ulcers are usually greater than 3cm in
    diameter.
  • May also reach upto 10cm (particularly on lesser
    curvature ).
  • Mortality rate is higher in these patients.
  • Size does not differentiate benign from malignant
    ulcer.
  • Some carcinomatous ulcers are less than 4cm and
    10
  • of benign ulcers are more than 4cm .

22
Gross features
  • Depth of penetration
  • Superficial ulcer penetrate the mucosa into the
    muscularis mucosae.
  • Deeply excavated ulcers having their bases on
    the muscularis propria.
  • Entire wall is penetrated and the ulcer base is
    adherant
  • to the pancreas, omental fat or liver. Free
    perforation into peritoneal cavity may occur.

23
Endoscopy
24
Biopsy of peptic ulcer
  • Biopsy is necessary to distinguish between benign
    and malignant ulcers.
  • Biopsy should be taken from the ulcer edge, at
    least from each quadrant.
  • Upto 10-12 biopsies may be taken to exclude
    cancer.
  • Repeat endoscopy may be necessary if biopsies
    are negative and there is high index of suspicion.

25
Microscopic features
  • Four distinct layers are present in a peptic
    ulcer.
  • Surface coat of purulent exudate, bacteria and
    necrotic debris.
  • Fibrinoid necrosis.
  • Granulation tissue.
  • Fibrosis replacing the muscle wall and extending
    into subserosa.

26
Management
  • MEDICAL TREATMENT
  • a) Antisceretory/Anti-acid Agents
  • 1) H2-blockers
  • 2) Proton-pump inhibitors
  • 3) Antacids
  • b) Cytoprotectives
  • 1) Misoprostil
  • 2) Sucralfate
  • c) H. pylori Agents

27
  • Eradication of H.pylori (proton pump inhibitor in
    combination with antibiotics)
  • Cessation of NSAIDS.
  • Criteria for reduction of the size of ulcer
    crater.
  • Reduction of crater size by 50 over 6-8 weeks
    of intensive medical management.
  • Endoscopic
  • SURGICAL TREATMENT

28
Differentials
  • Mesenteric ischemia
  • Angina pectoris
  • Biliary colic
  • Pancreatitis

29
Complication
  • Hemorrhage
  • Perforation
  • Penetration
  • Obstruction
  • Malignancy

30
(No Transcript)
31
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com